Sotagliflozin with insulin for treating type 1 diabetes (TA622)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 12 February 2020
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy (TA613)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 20 November 2019
Ticagrelor for preventing cardiovascular events in people with type 2 diabetes and coronary artery disease [ID1514]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Dulaglutide for treating type 2 diabetes [ID1451]Status:ProposedProgramme:Technology appraisal guidanceExpected publication date: TBC
Diabetes in pregnancy: management from preconception to the postnatal periodStatus:In developmentProgramme:NICE guidelineExpected publication date: TBC
Type 1 diabetes in adults: diagnosis and management (update)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC
Type 2 diabetes in adults: management (update)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC
Diabetes (type 1 and type 2) in children and young people: diagnosis and management (update)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]Status:ProposedProgramme:Technology appraisal guidanceExpected publication date: TBC